Karydo TherapeutiX ㈱
1 known investors
Karydo TherapeutiX (KarydoTX) develops a "Precision Human Digital-Twins System" (Precision hDTS) that measures molecular, cellular, organ, and inter-organ information in real time to create a live digital twin of the body, predicting future conditions to enable early detection, prevention, and treatment of disease. The company aims to contribute to a society of healthy longevity through this integrated, individually customized system.
Founders & leadership
TN
Thomas N. SatoScientific Founder
Investors · 1
Frequently asked questions
- What does Karydo TherapeutiX ㈱ do?
- Karydo TherapeutiX (KarydoTX) develops a "Precision Human Digital-Twins System" (Precision hDTS) that measures molecular, cellular, organ, and inter-organ information in real time to create a live digital twin of the body, predicting future conditions to enable early detection, prevention, and treatment of disease. The company aims to contribute to a society of healthy longevity through this integrated, individually customized system.
- Who founded Karydo TherapeutiX ㈱?
- Karydo TherapeutiX ㈱ was founded by Thomas N. Sato.
- Who are Karydo TherapeutiX ㈱'s investors?
- Karydo TherapeutiX ㈱'s investors include DBJ Capital.